Intelligence Platform
Patents
Browse 1,015 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6869604
Recombinant anti-tumor RNAse
expired patentUS 6849610
Polynucleotide ligands as anti-viral agents
expired patentUS 6838081
Methods for enhancing antigen-presenting cells and anti-tumor responses in a human patient
expired patentUS 6790939
Anti-PSCA antibodies
expired patentUS 6787571
Anti-inflammatory compounds derived from Pseudopterorgorgia elisabethae
expired patentUS 6756399
Use of lipoxygenase inhibitors and PPAR ligands as anti-cancer therapeutic and interventio
expired patentUS 6737051
Cell compositions containing macrophages, presenting anti-infectious and hematopoietic pro
expired patentUS 6730307
Anti-cryptosporidium parvum preparations
expired patentUS 6709649
RANTES derived peptides with anti-HIV activity
expired patentUS 6677309
Anti-cancer drug aldehyde conjugate drugs with enhanced cytotoxicity compounds, compositio
expired patentUS 6664263
1,8-naphthalimide imidazo{4,5,1-de}acridones with anti-tumor activity
expired patentUS 6653084
Anti-erbB-2 antibodies to human receptor related to but distinct from EGF receptor
expired patentUS 6649364
Anti-apoptotic compositions and methods using same
expired patentUS 6630167
Hyaluronic acid anti-adhesion barrier
expired patentUS 6620911
Anti-cryptococcal peptides
expired patentUS 6610302
Anti-tumor activity of Ea-2 and Ea-4-peptide of pro-IGF-I
expired patentUS 6576650
Peripherally active anti-hyperalgesic opiates
expired patentUS 6573282
Peripherally active anti-hyperalgesic opiates
expired patentUS 6573247
Anti-viral pyrimidine nucleoside analogues
expired patentUS 6565827
Radioimmunotherapy of lymphoma using anti-CD20 antibodies
expired patentUS 6528097
Sustained release non-steroidal, anti-inflammatory and lidocaine PLGA microspheres
expired patentUS 6500539
Anti-adhesion cellulose acetate wound dressing
expired patentUS 6497877
Plasminogen activator as an anti-inflammatory agent
expired patentUS 6479465
Methods of treating colitis using STAT-4 anti-sense oligonucleotides
expired